Literature DB >> 14626574

Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants--a reliable sterilization method.

Axel Pruss1, Ulf B Göbel, Georg Pauli, Moujahed Kao, Michael Seibold, Hans-Joachim Mönig, Arne Hansen, Rüdiger von Versen.   

Abstract

OBJECTIVES: Based on the European Standard EN 1040, the validation guidelines of the German Federal Institute for Drugs and Medical Devices and CPMP guidelines we tested the antimicrobial effectiveness of a peracetic acid-ethanol sterilization procedure (PES) in allogenic avital bone transplants. STUDY
DESIGN: Delipidated human bone spongiosa cubes (15 x 15 x 15 mm) served as tissue. Three enveloped viruses (human immunodeficiency virus type 2, pseudorabies virus, bovine virus diarrhoea virus) and three non-enveloped viruses (hepatitis A virus, poliovirus, porcine parvovirus) were used. The reduction of virus infectivity was measured as TCID50/ml in neutralized supernatants and bone homogenates. Staphylococcus aureus. Enterococcus faecium, Pseudomonas aeruginosa. Bacillus subtilis. Clostridium sporogenes, Mycobacterium terrae. Candida albicans, Aspergillus niger as well as spores of Bacillus subtilis were tested additionally. PES led to a reduction of virus titres by more than 4 log10. Only HAV showed a reduction below 4 log10 (2.87) with residual infectivity. After including a delipidating step for HAV-infected cells, a reduction of over 7 log10 HAV titre was found. For viable bacteria, fungi and spores a titre reduction below the detection level (5 log10) was achieved after an incubation time of 2 hours.
CONCLUSIONS: The peracetic acid-ethanol procedure proved to be a reliable method for the sterilization of human bone transplants (layer thickness < or = 15 mm). However, additional safety measures (anamnestic informations, infectious serology, HIV-/HBV-/HCV-PCR in case of multiorgan donors) should be taken.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14626574

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  25 in total

1.  [Reconstruction of the extensor mechanism using a free, allogenic, freeze-dried patellar graft].

Authors:  D Krocker; G Matziolis; A Pruss; C Perka
Journal:  Unfallchirurg       Date:  2007-06       Impact factor: 1.000

2.  [Musculoskeletal tissue banks. Legal foundations and graft safety].

Authors:  A Prub; B-D Katthagen
Journal:  Orthopade       Date:  2008-08       Impact factor: 1.087

Review 3.  Amniotic membrane in oral and maxillofacial surgery.

Authors:  Marco Rainer Kesting; Klaus-Dietrich Wolff; Christopher Philipp Nobis; Nils Hagen Rohleder
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

4.  CT Lesion Model-Based Structural Allografts: Custom Fabrication and Clinical Experience.

Authors:  Jan Claas Brune; Uwe Hesselbarth; Philipp Seifert; Dimitri Nowack; Rüdiger von Versen; Mark David Smith; Dirk Seifert
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

Review 5.  [Prevention of infections due to musculoskeletal allografts].

Authors:  A Pruß
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 6.  [Bone banks : The state-of-the-art].

Authors:  A Pruß; U Kalus
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

Review 7.  Radiation sterilization of tissue allografts: A review.

Authors:  Rita Singh; Durgeshwer Singh; Antaryami Singh
Journal:  World J Radiol       Date:  2016-04-28

8.  [Consequence of European Directive 2004/23/EC for bone banks in Germany].

Authors:  A Pruss; H Knaepler; B-D Katthagen; L Frommelt
Journal:  Orthopade       Date:  2005-11       Impact factor: 1.087

9.  Quantification of growth factors in allogenic bone grafts extracted with three different methods.

Authors:  B Wildemann; A Kadow-Romacker; A Pruss; N P Haas; G Schmidmaier
Journal:  Cell Tissue Bank       Date:  2006-10-25       Impact factor: 1.522

10.  Remodeling of ACL allografts is inhibited by peracetic acid sterilization.

Authors:  Sven U Scheffler; Johannes Gonnermann; Julia Kamp; Dorothea Przybilla; Axel Pruss
Journal:  Clin Orthop Relat Res       Date:  2008-05-20       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.